Hara Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hara Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-95	Closed	-$11.7K	–	317
2024 Q4	$11.7K	Hold	95	–	–	0.01%	240
2024 Q3	$10.6K	Buy	+95	New	+$10.4K	0.01%	247

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Hara Capital's JAZZ Position: Q1 2025 in Review

Hara Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 95 shares — an estimated $11.7K sold.

Hara Capital first reported a position in JAZZ in Q3 2024 and held it in 2 quarters. The position peaked at $11.7K in Q4 2024. 551 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

Hara Capital reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Hara Capital sold 95 Jazz Pharmaceuticals shares in Q1 2025, an estimated $11.7K.
Hara Capital first reported a position in Jazz Pharmaceuticals in Q3 2024 and held it in 2 quarters.
Hara Capital's Jazz Pharmaceuticals position peaked at $11.7K in Q4 2024.
551 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on Hara Capital's 13F filing for Q1 2025, filed 30 Apr 2025.